Search Results
10
Everything
Search Filters
Tag
Biotech
Silexion Therapeutics Announces 1-for-9 Reverse Share Split
November 22, 2024 16:30 ET
|
Silexion Therapeutics Corp
GRAND CAYMAN, Cayman Islands, November 22, 2024 – Silexion Therapeutics Corp. (NASDAQ: SLXN) (“Silexion” or the “Company”), a clinical-stage biotech developing RNA interference (RNAi) therapies for...
Syncell’s Microscoop Winner of BioTech Breakthrough Award For “Proteomics Solution of the Year”
November 21, 2024 20:16 ET
|
BioTech Breakthrough
TAIPEI, Taiwan and WATERTOWN, Mass., Nov. 21, 2024 (GLOBE NEWSWIRE) -- Syncell, a leader in next-generation subcellular protein purification and spatial proteomics analysis, today announced that...
FDA clears XENOVIEW® 3T Chest Coil in GE HealthCare MRI Systems
November 21, 2024 08:28 ET
|
Polarean
DURHAM, NC and LONDON, Nov. 21, 2024 (GLOBE NEWSWIRE) -- Polarean Imaging plc (AIM: POLX) (“Polarean” or the “Company”), a commercial-stage medical imaging technology leader in advanced Magnetic...
Upstream Bio to Participate in the Piper Sandler 36th Annual Healthcare Conference
November 21, 2024 08:00 ET
|
Upstream Bio
Upstream Bio CEO to participate in fireside chat at Piper Sandler
Biolojic Design Appoints Neal Curran as Chief Business Officer
November 21, 2024 08:00 ET
|
Biolojic Design
Biolojic Design announced the appointment of Neal Curran as Chief Business Officer.
Conduit Pharmaceuticals Receives Further Patent Approval For Lead Asset Targeting Autoimmune Disorders
November 21, 2024 07:30 ET
|
Conduit Pharmaceuticals
Conduit Pharmaceuticals Receives Further Patent Approval For Lead Asset Targeting Autoimmune Disorders
Silexion Therapeutics to Present at the Noble Capital Markets 20th Annual Emerging Growth Equity Conference
November 20, 2024 08:30 ET
|
Silexion Therapeutics Corp
GRAND CAYMAN, CAYMAN ISLANDS, Silexion Therapeutics Corp. (NASDAQ: SLXN) (“Silexion” or the “Company”), a clinical-stage biotech developing RNA interference (RNAi) therapies for KRAS-driven cancers,...
Abivax Establishes an At-the-Market (ATM) Program on Nasdaq
November 19, 2024 16:30 ET
|
Abivax
Abivax Establishes an At-the-Market (ATM) Program on Nasdaq PARIS, France, November 19, 2024 – 10:30PM CET – Abivax SA (Euronext Paris: FR0012333284 – ABVX / Nasdaq - ABVX) (“Abivax” or the...
Synata Bio’s Sylonto Project Awarded $4.5 Million NDRC Grant
November 19, 2024 09:57 ET
|
Synata Bio Inc
Synata Bio, a U.S. company converting waste gases into ethanol, has received a $4.5 million grant from China’s NDRC for its Sylonto project.
Biopharma Leaders of Color (BLOC) Announces Board of Directors and Establishes Executive Council to Expand and Enhance Offerings
November 19, 2024 09:00 ET
|
Biopharma Leaders of Color, Inc.
Biopharma Leaders of Color (BLOC) Announces Board of Directors and Establishes Executive Council to Expand and Enhance Offerings